EP3243821
PHARMACEUTICAL FORMULATIONS FOR REGULATING INTEGRIN CD11B/CD18
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.5.2011EP published:
26.2.2020EP application number:
17177006.8
EPO information:
European Patent Register
Max expiry date:
1.5.2031
Title:
PHARMACEUTICAL FORMULATIONS FOR REGULATING INTEGRIN CD11B/CD18
Timeline
Today
2.5.2011EP application
26.2.2020EP Publication
Owner
Name:
GB006, Inc.Address:
3013 Science Park Road, Suite 200, San Diego, CA 92121, US
Inventor
Name:
GUPTA, VineetAddress:
Pinecrest, FL 33156, US
Priority
Number:
362363 PDate:
8.7.2010Country:
US
Classification
Categories:
C07D 417/06, A61K 31/427, A61P 29/00